155 related articles for article (PubMed ID: 19378021)
1. Innate immunity, Toll-like receptors, and atherosclerosis: mouse models and methods.
Sorrentino R; Arditi M
Methods Mol Biol; 2009; 517():381-99. PubMed ID: 19378021
[TBL] [Abstract][Full Text] [Related]
2. Multiple roles of Toll-like receptor signaling in atherosclerosis.
Björkbacka H
Curr Opin Lipidol; 2006 Oct; 17(5):527-33. PubMed ID: 16960501
[TBL] [Abstract][Full Text] [Related]
3. Innate immunity, macrophage activation, and atherosclerosis.
Yan ZQ; Hansson GK
Immunol Rev; 2007 Oct; 219():187-203. PubMed ID: 17850490
[TBL] [Abstract][Full Text] [Related]
4. Innate immune signals in atherosclerosis.
Lundberg AM; Hansson GK
Clin Immunol; 2010 Jan; 134(1):5-24. PubMed ID: 19740706
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor signaling and atherosclerosis.
Michelsen KS; Arditi M
Curr Opin Hematol; 2006 May; 13(3):163-8. PubMed ID: 16567960
[TBL] [Abstract][Full Text] [Related]
6. Innate immune recognition receptors and damage-associated molecular patterns in plaque inflammation.
Lundberg AM; Yan ZQ
Curr Opin Lipidol; 2011 Oct; 22(5):343-9. PubMed ID: 21881501
[TBL] [Abstract][Full Text] [Related]
7. Hypertonic saline enhances host defense to bacterial challenge by augmenting Toll-like receptors.
Chen LW; Huang HL; Lee IT; Hsu CM; Lu PJ
Crit Care Med; 2006 Jun; 34(6):1758-68. PubMed ID: 16625117
[TBL] [Abstract][Full Text] [Related]
8. Specific loss of toll-like receptor 2 on bone marrow derived cells decreases atherosclerosis in LDL receptor null mice.
Hasu M; Thabet M; Tam N; Whitman SC
Can J Physiol Pharmacol; 2011 Oct; 89(10):737-42. PubMed ID: 21895526
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptors in atherosclerosis.
Tobias PS; Curtiss LK
Biochem Soc Trans; 2007 Dec; 35(Pt 6):1453-5. PubMed ID: 18031244
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptors and atherosclerosis: key contributors in disease and health?
Mullick AE; Tobias PS; Curtiss LK
Immunol Res; 2006; 34(3):193-209. PubMed ID: 16891671
[TBL] [Abstract][Full Text] [Related]
11. Increased mucosal expression of Toll-like receptor (TLR)2 and TLR4 in coeliac disease.
Szebeni B; Veres G; Dezsofi A; Rusai K; Vannay A; Bokodi G; Vásárhelyi B; Korponay-Szabó IR; Tulassay T; Arató A
J Pediatr Gastroenterol Nutr; 2007 Aug; 45(2):187-93. PubMed ID: 17667714
[TBL] [Abstract][Full Text] [Related]
12. The roles of Toll-like receptors in atherosclerosis.
Erridge C
J Innate Immun; 2009; 1(4):340-9. PubMed ID: 20375591
[TBL] [Abstract][Full Text] [Related]
13. Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms.
Loppnow H; Werdan K; Buerke M
Innate Immun; 2008 Apr; 14(2):63-87. PubMed ID: 18713724
[TBL] [Abstract][Full Text] [Related]
14. Treating atherosclerosis: the potential of Toll-like receptors as therapeutic targets.
Cole JE; Mitra AT; Monaco C
Expert Rev Cardiovasc Ther; 2010 Nov; 8(11):1619-35. PubMed ID: 21090937
[TBL] [Abstract][Full Text] [Related]
15. Innate immunity to mycobacterial infection in mice: critical role for toll-like receptors.
Ryffel B; Fremond C; Jacobs M; Parida S; Botha T; Schnyder B; Quesniaux V
Tuberculosis (Edinb); 2005; 85(5-6):395-405. PubMed ID: 16257265
[TBL] [Abstract][Full Text] [Related]
16. Innate immunity conferred by Toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation.
Liu-Bryan R; Scott P; Sydlaske A; Rose DM; Terkeltaub R
Arthritis Rheum; 2005 Sep; 52(9):2936-46. PubMed ID: 16142712
[TBL] [Abstract][Full Text] [Related]
17. The complement system and toll-like receptors as integrated players in the pathophysiology of atherosclerosis.
Hovland A; Jonasson L; Garred P; Yndestad A; Aukrust P; Lappegård KT; Espevik T; Mollnes TE
Atherosclerosis; 2015 Aug; 241(2):480-94. PubMed ID: 26086357
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptors as targets for immune disorders.
Keogh B; Parker AE
Trends Pharmacol Sci; 2011 Jul; 32(7):435-42. PubMed ID: 21529972
[TBL] [Abstract][Full Text] [Related]
19. Innate immunity to pneumococcal infection of the central nervous system depends on toll-like receptor (TLR) 2 and TLR4.
Klein M; Obermaier B; Angele B; Pfister HW; Wagner H; Koedel U; Kirschning CJ
J Infect Dis; 2008 Oct; 198(7):1028-36. PubMed ID: 18700834
[TBL] [Abstract][Full Text] [Related]
20. Vascular cell responsiveness to Toll-like receptor ligands in carotid atheroma.
Erridge C; Burdess A; Jackson AJ; Murray C; Riggio M; Lappin D; Milligan S; Spickett CM; Webb DJ
Eur J Clin Invest; 2008 Oct; 38(10):713-20. PubMed ID: 18837796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
